During the past decade, Norton Neuroscience Institute conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Norton Neuroscience Institute" #1 sponsor was "Astellas Pharma Inc" with 2 trials, followed by "Medtronic Neurovascular Clinical Affairs" with 2 trials sponsored, "C. R. Bard" with 1 trials sponsored, "Eisai Inc." with 1 trials sponsored and "Medtronic Cardiac Rhythm and Heart Failure" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Norton Neuroscience Institute" #1 collaborator was "Astellas Pharma US, Inc." with 2 trials as a collaborator, "Boston University" with 1 trials as a collaborator, "Stryker Neurovascular" with 1 trials as a collaborator and "Yale University" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Norton Neuroscience Institute" are "Ischemic Stroke" (2 trials), "Acute Ischemic Stroke" (1 trials), "Aneurysm" (1 trials), "Brain Aneurysm" (1 trials) and "Brain Aneurysms" (1 trials). Many other conditions were trialed in "Norton Neuroscience Institute" in a lesser frequency.

Most popular intervention types in "Norton Neuroscience Institute" are "Device" (5 trials), "Drug" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Flow Re-Direction Endoluminal Device (FRED)" (1 trials), "Mechanical thrombectomy" (1 trials), "Minimally invasive surgery" (1 trials), "Pipeline Embolization Device" (1 trials) and "RNS System" (1 trials). Other intervention names were less common.

The vast majority of trials in "Norton Neuroscience Institute" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Norton Neuroscience Institute". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Norton Neuroscience Institute, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Norton Neuroscience Institute, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".